Spots Global Cancer Trial Database for vaccines
Every month we try and update this database with for vaccines cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI | NCT01885702 | Colorectal Canc... | DC vaccination | 18 Years - 75 Years | Radboud University Medical Center | |
| Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer | NCT03300843 | Melanoma Gastrointestina... Breast Cancer Ovarian Cancer Pancreatic Canc... | Peptide loaded ... | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG | NCT02015104 | Bladder Cancer | BCG intravesica... PANVAC | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients | NCT02692976 | Prostatic Neopl... Immunotherapy Dendritic Cells Vaccines | mDC vaccination pDC vaccination mDC and pDC vac... | 18 Years - | Radboud University Medical Center | |
| Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG | NCT02015104 | Bladder Cancer | BCG intravesica... PANVAC | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients | NCT01530698 | Melanoma | autologous dend... autologous dend... | 18 Years - 70 Years | Radboud University Medical Center | |
| Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients | NCT00940004 | Melanoma | autologous dend... | 18 Years - 70 Years | Radboud University Medical Center | |
| A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls | NCT02834637 | Human Papilloma... | bivalent HPV va... nonavalent HPV ... | 9 Years - 14 Years | London School of Hygiene and Tropical Medicine | |
| Novel RNA-nanoparticle Vaccine for the Treatment of Early Melanoma Recurrence Following Adjuvant Anti-PD-1 Antibody Therapy | NCT05264974 | Melanoma | Autologous tota... | 18 Years - 99 Years | University of Florida | |
| Study of RNA-lipid Particle (RNA-LP) Vaccines for Recurrent Pulmonary Osteosarcoma (OSA) | NCT05660408 | Pulmonary Osteo... | RNA-LP vaccine | 0 Years - 39 Years | University of Florida | |
| Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer | NCT03300843 | Melanoma Gastrointestina... Breast Cancer Ovarian Cancer Pancreatic Canc... | Peptide loaded ... | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma | NCT00090493 | Multiple Myelom... | MAGE-A3 MAGE-A3 AND NY-... | 18 Years - 70 Years | University of Arkansas | |
| Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients | NCT01530698 | Melanoma | autologous dend... autologous dend... | 18 Years - 70 Years | Radboud University Medical Center | |
| Vaccine Responses in Patients With B Cell Malignancies | NCT05170399 | Lymphoma | Fluzone Shingrix Flucelvax Afluria PREVNAR 13 Heplisav -B Pfizer-COVID-19... FluLaval Fluarix PNEUMOVAX 23 PREVNAR 20 AREXVY, ABRYSVO | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | |
| Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG | NCT02015104 | Bladder Cancer | BCG intravesica... PANVAC | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
